Back to results
US 2017/0304346 A1Published application
Use of nadh or salt thereof in preparation of drugs or health-care products for treating phenylketonuria
AssigneeBontac Bio-Engineering (Shenzhen) Co., Ltd
InventorsRongzhao FU, Qi ZHANG, Yuemei LIU
Life of this patent
Estimating the term…
Abstract
Disclosed is use of nicotinamide adenine dinucleotide (NADH) or a salt thereof in the preparation of drugs or health-care products for treating phenylketonuria (PKU), wherein a single dose of the NADH or a salt thereof is 1-100 mg.
Claims8
1-7. (canceled)
A method of treating phenylketonuria (PKU), comprising the step of administering to a patient suffering from phenylketonuria a therapeutic effective amount of NADH or a salt thereof or a composition containing NADH or a salt thereof and pharmaceutically acceptable excipients.
Dependencies are inferred from the claim text.